# FDA EIR - KBI Biopharma, Inc. - March 06, 2020

Source: https://www.globalkeysolutions.net/records/eir/kbi-biopharma-inc/51d34223-d6bd-4055-8159-1b61f966c64a

> FDA EIR for KBI Biopharma, Inc. on March 06, 2020. Product: Biologics. Access full analysis and detailed observations.

---

## Details

- Record Type: EIR
- Company Name: KBI Biopharma, Inc.
- Inspection Date: 2020-03-06
- Product Type: Biologics
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [EIR - Unknown Date](https://www.globalkeysolutions.net/records/eir/kbi-biopharma-inc/ccfb6e91-501e-495d-8170-0125c353d292)

## Related Officers

- [Compliance Officer / Investigator](https://www.globalkeysolutions.net/people/erika-v-butler/3e654530-4c29-403d-880e-a5422315c3c0)
- [company_representative](https://www.globalkeysolutions.net/people/sandra-lueken/67d6e1ab-e935-4aa5-960a-e5125ae51ef2)
- [other](https://www.globalkeysolutions.net/people/tim-lowery/8680f65a-ebb2-49a5-b324-7eb3a51107a6)
- [company_representative](https://www.globalkeysolutions.net/people/kathy-s-lee/9a58a1d6-cf0c-4fa2-8eed-e17b5cc7d469)
- [company_representative](https://www.globalkeysolutions.net/people/david-cain/a2d9cb5a-0d44-46bb-a151-e555d8a89dc2)

Company: https://www.globalkeysolutions.net/companies/kbi-biopharma-inc/0116f415-95dd-4a3f-a854-182d0314d5a5

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c